Peter J Barris - Net Worth and Insider Trading

Peter J Barris Net Worth

The estimated net worth of Peter J Barris is at least $2.5 Billion dollars as of 2024-04-16. Peter J Barris is the 10% Owner of Tesaro Inc and owns about 10,422,179 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Peter J Barris is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Peter J Barris is also the 10% Owner of Supernus Pharmaceuticals Inc and owns about 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $230 Million. Besides these, Peter J Barris also holds Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Adaptimmune Therapeutics PLC (ADAP) , Ardelyx Inc (ARDX) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , GlycoMimetics Inc (GLYC) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Senseonics Holdings Inc (SENS) , Trevi Therapeutics Inc (TRVI) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) . Details can be seen in Peter J Barris's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter J Barris has not made any transactions after 2019-12-26 and currently still holds the listed stock(s).

Transaction Summary of Peter J Barris

To

Peter J Barris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter J Barris owns 86 companies in total, including Sprout Social Inc () , Groupon Inc () , and Regulus Therapeutics Inc () among others .

Click here to see the complete history of Peter J Barris’s form 4 insider trades.

Insider Ownership Summary of Peter J Barris

Ticker Comapny Transaction Date Type of Owner
Sprout Social Inc 2019-12-12 director & 10 percent owner
Groupon Inc 2019-12-26 director & 10 percent owner
Regulus Therapeutics Inc 2019-05-07 10 percent owner
Ardelyx Inc 2016-07-18 10 percent owner
Proteostasis Therapeutics Inc 2019-11-26 10 percent owner
Galera Therapeutics Inc 2019-11-06 10 percent owner
Oyster Point Pharma Inc 2019-10-30 10 percent owner
Cloudflare Inc 2019-09-12 10 percent owner
Mirum Pharmaceuticals Inc 2019-07-22 10 percent owner
Genocea Biosciences Inc 2019-06-24 10 percent owner
Nightstar Therapeutics PLC 2019-06-07 10 percent owner
Trevi Therapeutics Inc 2019-05-09 10 percent owner
AVEO Pharmaceuticals Inc 2019-04-08 10 percent owner
Mersana Therapeutics Inc 2017-07-03 10 percent owner
Tesaro Inc 2019-01-22 10 percent owner
Ra Pharmaceuticals Inc 2018-12-14 10 percent owner
Millendo Therapeutics Inc 2018-12-07 10 percent owner
PhaseBio Pharmaceuticals Inc 2018-10-17 10 percent owner
Marker Therapeutics Inc 2018-10-17 10 percent owner
Elastic NV 2018-10-04 10 percent owner
Adaptimmune Therapeutics PLC 2018-09-07 10 percent owner
Liquidia Corp 2018-07-30 10 percent owner
Bloom Energy Corp 2018-07-24 10 percent owner
GlycoMimetics Inc 2018-05-10 10 percent owner
MuleSoft Inc 2018-05-01 10 percent owner
Surface Oncology Inc 2018-04-23 10 percent owner
TRACON Pharmaceuticals Inc 2018-03-27 10 percent owner
Cascadian Therapeutics Inc 2018-03-09 10 percent owner
ARCA biopharma Inc 2018-02-26 10 percent owner
Tintri Inc 2018-02-26 10 percent owner
Appian Corp 2017-11-27 10 percent owner
Synlogic Inc 2015-09-30 10 percent owner
Strongbridge Biopharma PLC 2018-01-01 10 percent owner
Senseonics Holdings Inc 2017-12-08 10 percent owner
X4 Pharmaceuticals Inc 2017-11-20 10 percent owner
Care.com Inc 2017-11-06 10 percent owner
Rhythm Pharmaceuticals Inc 2017-10-10 10 percent owner
Zosano Pharma Corp 2015-01-26 10 percent owner
Achaogen Inc 2016-12-19 10 percent owner
Xtera Communications Inc 2016-10-11 10 percent owner
Sorrento Tech Inc 2016-09-21 10 percent owner
Interleukin Genetics Inc 2016-07-29 10 percent owner
Opower Inc 2016-06-14 10 percent owner
TriVascular Technologies Inc 2016-02-03 10 percent owner
Epizyme Inc 2016-01-12 10 percent owner
Supernus Pharmaceuticals Inc 2015-06-17 10 percent owner
Avalo Therapeutics Inc 2015-10-14 10 percent owner
Vitae Pharmaceuticals Inc 2015-07-01 10 percent owner
Champions Oncology Inc 2015-03-11 10 percent owner
Box Inc 2015-01-22 10 percent owner
Boingo Wireless Inc 2014-12-19 10 percent owner
Trevena Inc 2014-01-30 10 percent owner
Tableau Software Inc 2014-12-02 10 percent owner
Cvent Inc 2014-11-25 10 percent owner
Dermira Inc 2014-10-08 10 percent owner
Sunesis Pharmaceuticals Inc 2014-08-27 10 percent owner
Loxo Oncology Inc 2014-08-06 10 percent owner
Aerohive Networks Inc 2014-04-02 10 percent owner
ChannelAdvisor Corp 2013-05-22 10 percent owner
Catalyst Biosciences Inc 2013-12-05 10 percent owner
Xoom Corp 2013-10-29 10 percent owner
Clovis Oncology Inc 2011-11-21 10 percent owner
Workday Inc 2012-10-11 10 percent owner
Millennial Media Inc 2012-10-29 10 percent owner
Vonage Holdings Corp 2006-05-23 director & 10 percent owner
InnerWorkings Inc 2012-05-30 director
Amicus Therapeutics Inc 2012-03-07 10 percent owner
Echo Global Logistics Inc 2012-03-05 director & 10 percent owner
Inteliquent Inc 2011-11-16 director
Glu Mobile Inc 2011-08-08 10 percent owner
ARYx Therapeutics Inc 2011-03-10 10 percent owner
Financial Engines Inc 2010-08-30 10 percent owner
Voltari Corp 2010-06-23 10 percent owner
W World Corp 2009-05-08 10 percent owner
Paratek Pharmaceuticals Inc 2006-05-09 10 percent owner
DZS Inc 2007-08-14 10 percent owner
Aradigm Corp 2004-02-20 10 percent owner
Viracta Therapeutics Inc 2009-04-03 10 percent owner
Yumanity Therapeutics Inc 2016-02-10 10 percent owner
Tempest Therapeutics Inc 2018-12-07 10 percent owner
Berkshire Grey Inc 2023-07-20 director
NextNav Inc 2021-10-28 director
ZeroFox Holdings Inc 2022-08-03 director
Kineta Inc 2016-02-10 10 percent owner
Genocea Biosciences Inc 2018-01-19 10 percent owner
Revolution Acceleration Acquisition Corp 2023-07-20 director

Peter J Barris Latest Holdings Summary

Peter J Barris currently owns a total of 34 stocks. Among these stocks, Peter J Barris owns 10,422,179 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 31.33%. Peter J Barris owns 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 17.41%. Peter J Barris also owns 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) as of June 17, 2015, with a value of $230 Million and a weighting of 9.21%. The other 31 stocks Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Adaptimmune Therapeutics PLC (ADAP) , Ardelyx Inc (ARDX) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , GlycoMimetics Inc (GLYC) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Senseonics Holdings Inc (SENS) , Trevi Therapeutics Inc (TRVI) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) have a combined weighting of 42.05% among all his current holdings.

Latest Holdings of Peter J Barris

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSRO Tesaro Inc 2018-03-06 10,422,179 74.96 781,246,538
FNIO iShares Indl/Office Real Estate Capped 2012-04-30 13,610,551 31.89 434,040,471
SUPN Supernus Pharmaceuticals Inc 2015-06-17 7,716,055 29.76 229,629,797
RYTM Rhythm Pharmaceuticals Inc 2017-10-10 4,909,956 40.07 196,717,387
RARX Ra Pharmaceuticals Inc 2016-10-31 3,490,073 47.99 167,488,603
MIRM Mirum Pharmaceuticals Inc 2019-07-22 4,186,243 24.64 103,128,096
ADAP Adaptimmune Therapeutics PLC 2018-09-07 94,978,668 1.03 97,353,135
ARDX Ardelyx Inc 2016-07-18 14,084,162 6.74 94,856,831
ECHO Echo Global Logistics Inc 2012-03-05 1,420,901 48.24 68,544,264
WIFI Boingo Wireless Inc 2013-12-11 4,469,108 13.99 62,522,821
FOLD Amicus Therapeutics Inc 2012-03-07 5,650,340 10.59 59,808,849
AVEO AVEO Pharmaceuticals Inc 2019-04-08 2,524,387 15.00 37,865,805
LQDA Liquidia Corp 2018-07-30 2,484,870 13.73 34,118,756
MRSN Mersana Therapeutics Inc 2017-07-03 8,140,138 3.77 30,647,620
GLYC GlycoMimetics Inc 2018-05-10 9,089,041 2.23 20,268,561
MM Millennial Media Inc 2012-10-29 8,196,614 1.75 14,344,075
INWK InnerWorkings Inc 2012-05-30 4,566,835 2.99 13,654,837
SENS Senseonics Holdings Inc 2017-12-08 30,936,643 0.44 13,582,733
TRVI Trevi Therapeutics Inc 2019-05-09 4,438,562 2.66 11,806,575
EPZM Epizyme Inc 2016-01-12 6,261,599 1.47 9,204,551
DATA Tableau Software Inc 2014-08-25 40,077 169.53 6,794,254
SURF Surface Oncology Inc 2018-04-23 3,312,877 1.07 3,544,778
RGLS Regulus Therapeutics Inc 2019-05-07 205,245 2.58 529,532
GRPN Groupon Inc 2019-12-26 42,476 10.19 432,983
CBIO Catalyst Biosciences Inc 2013-12-05 43,462 7.67 333,332
DERM Dermira Inc 2014-10-02 17,241 18.75 323,269
ILIU Interleukin Genetics Inc 2016-07-29 55,418,811 0.00 249,385
AKAOQ Achaogen Inc 2016-12-19 5,215,128 0.03 130,378
CLVSQ Clovis Oncology Inc 2011-11-21 3,419,671 0.02 51,295
TCON TRACON Pharmaceuticals Inc 2018-03-27 17,330 1.74 30,154
GNCAQ Genocea Biosciences Inc 2019-06-24 7,225,676 0.00 723
NOVCQ Novation Companies Inc 2006-05-15 1,225,179 0.00 123
ABIO ARCA biopharma Inc 2018-02-26 0 3.13 0
APPN Appian Corp 2017-11-27 0 36.61 0

Holding Weightings of Peter J Barris


Peter J Barris Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Peter J Barris around $8 Million.

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 16,101 shares on April 30, 2012, which brought Peter J Barris around $427,160.

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 111,881 shares on June 17, 2015, which brought Peter J Barris around $2 Million.

More details on Peter J Barris's insider transactions can be found in the Insider Trading History of Peter J Barris table.

Insider Trading History of Peter J Barris

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter J Barris Trading Performance

GuruFocus tracks the stock performance after each of Peter J Barris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter J Barris is 8.04%. GuruFocus also compares Peter J Barris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter J Barris within 3 months outperforms 25 times out of 48 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter J Barris's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter J Barris

Average Relative Return

-14.7%

Average relative return per transaction

Outperforming Transactions

26%

12 out of 47 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 6.76 8.04 6.96 -14.7 -25.51 -23.17
Relative Return to S&P 500(%) 6.17 4.99 0.96 -26.56 -36.99 -35.89

Peter J Barris Ownership Network

Ownership Network List of Peter J Barris

No Data

Ownership Network Relation of Peter J Barris


Peter J Barris Owned Company Details

What does Sprout Social Inc do?

Who are the key executives at Sprout Social Inc?

Peter J Barris is the director & 10 percent owner of Sprout Social Inc. Other key executives at Sprout Social Inc include director & 10 percent owner & Chairman and CEO Justyn Russell Howard , President Ryan Paul Barretto , and director & 10 percent owner & Chief Technology Officer Rankin Aaron Edward Frederick .

Sprout Social Inc () Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Sprout Social Inc (). Other recent insider transactions involving Sprout Social Inc () include a net sale of 40,801 shares made by Preto Joseph Del , a net sale of 435,000 shares made by Justyn Russell Howard , and a net sale of 276,051 shares made by Rankin Aaron Edward Frederick .

In summary, during the past 3 months, insiders sold 251,540 shares of Sprout Social Inc () in total and bought 0 shares, with a net sale of 251,540 shares. During the past 18 months, 968,765 shares of Sprout Social Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 968,765 shares.

Sprout Social Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sprout Social Inc Insider Transactions

No Available Data

Peter J Barris Mailing Address

Above is the net worth, insider trading, and ownership report for Peter J Barris. You might contact Peter J Barris via mailing address: 1119 St Paul Street, Baltimore Md 21202.

Discussions on Peter J Barris

No discussions yet.